Showing 2571-2580 of 8826 results for "".
Top Dermatology Marketing Trends for 2023
https://practicaldermatology.com/topics/practice-management/top-dermatology-marketing-trends-for-2023/23862/Are you up to date on trends in digital marketing?Update on Photoprotection
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-photoprotection/23735/An update on what dermatologists can tell patients about vitamin D and filters available overseas.What’s New in Nonmelanoma Skin Cancer Treatment?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/whats-new-in-nonmelanoma-skin-cancer-treatment/23895/Recent research explores a growing range of nonsurgical options.Getting to Know Juvéderm Volbella XC
https://practicaldermatology.com/topics/practice-management/getting-to-know-juvderm-volbella-xc/20864/CSF faculty members share Volbella pearls.Treating Psoriasis with FDA-Approved Medications in 2020
https://practicaldermatology.com/topics/psoriasis/treating-psoriasis-with-fda-approved-medications-in-2020/23212/A reference for all of the FDA-approved medications separated into topical treatments and systemic treatments.Cognitive Bias And The Art of Doctoring
https://practicaldermatology.com/topics/practice-management/cognitive-bias-and-the-art-of-doctoring/23680/Rethinking the approach to diagnosis may reduce errors and improve patient interactions.Rhatigan to Merz, MOC Dissatisfaction, Syneron-Candela Sale
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhatigan-to-merz-moc-dissatisfaction-syneron-candela-sale/18485/Industry veteran Bob Rhatigan is the new President and Chief Executive Officer of Merz North America. Patrick Urban is new Chief Commercial Officer. In a transaction valued at approximately $397 million, an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of SyAre We What We Eat?
https://practicaldermatology.com/columns/clinical-focus-1/are-we-what-we-eat/23507/Understanding adverse food reactions and their role in atopic dermatitis.Turmeric, Curcumin, and Curcuminoids: A Dermatologic Review
https://practicaldermatology.com/columns/clinical-focus-1/turmeric-curcumin-and-curcuminoids-a-dermatologic-review/23377/Curcumin, one of the active compounds of turmeric, exhibits anti-inflammatory, antimicrobial, antioxidant, anti-nociceptive, and antineoplastic properties.Case Report: Treatment of Refractory Pemphigus Foliaceus with Rituximab; Financial Matters; AAD; ASDS Resources
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-treatment-of-refractory-pemphigus-foliaceus-with-rituximab-financial-matters-aad-asds-resources/21033/